Chronic hepatitis B affects millions worldwide and remains a major driver of liver-related morbidity and mortality. Emerging therapies, including antivirals and immunomodulators, have shown promise in clinical trials, offering new hope for achieving functional cure. Join Dr. Joseph Lim as he explores the mechanisms of action and recent clinical data shaping future treatment strategies for chronic HBV.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
56 of 56 courses listed here are free.
Collected from the provider’s public pages
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Board review / self-assessment
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedSep 5, 2025
-
Last day to claim creditNov 1, 2026 3 weeks left
-
Clinical Care Options, LLC (dba Decera Clinical Education) Beyond the Status Quo: Exploring the Future Impact of HBV Innovations
-
American Association for the Study of Liver Diseases Guideline Update: Practice Guideline of Chronic Hepatitis B
-
PVI, PeerView Institute for Medical Education Toward Functional Cure in Chronic HBV: Monitoring, Serological Markers, and Evolving Therapy
